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Abstract The enzyme telomerase is necessary for the synthesis
and maintenance of telomere length. The catalytic subunit, te-
lomerase reverse transcriptase (TERT), is regulated by interac-
tion with the 90 kDa heat shock protein (HSP90) and by Akt-
dependent phosphorylation. Here, we demonstrate that HSP90
and Akt physically interact with TERT. Treatment of cells with
novobiocin, which blocks C-terminal interaction of HSP90, dis-
rupted HSP90 binding to Akt, induced Akt dephosphorylation
and signi¢cantly reduced telomerase activity. The reduction of
TERT activity by novobiocin was associated with an increase in
apoptosis. Likewise, the induction of Akt dephosphorylation by
protein phosphatase 2A (PP2A) reduced telomerase activity.
HSP90 is known to prevent PP2A-mediated dephosphorylation
of Akt. To investigate whether the e¡ect of novobiocin is due to
the reduction of Akt or TERT phosphorylation, we over-
expressed a phospho-mimetic, active Akt (T308D/S473D).
Akt(T308D/S473D) prevented novobiocin-induced reduction of
telomerase activity and the stimulation of apoptosis. More-
over, overexpression of a dominant negative PP2A construct
(PP2A(L199P)) as well as incubation with the PP2A inhibitor
okadaic acid blocked the inhibition of telomerase activity by
novobiocin. These data suggest that the association between
HSP90, Akt and TERT in concert with the phosphorylation
of TERT is necessary for maintaining telomerase activity and
inhibition of apoptosis.
4 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Telomeres are the physical ends of the chromosomes. They
are composed of the repeated sequence TTAGGG and are
responsible for maintaining chromosomal stability and integ-
rity [1,2]. Telomeres can function as a mitotic clock, since
telomeres are progressively shortened during each cell divi-
sion. Telomere shortening forces human primary cells to
stop dividing, when a critical minimum telomere length is
reached [3,4]. At a critical point of 7 kb of telomere length
cells come into the state of cellular senescence. However, re-
cent data by Karlseder et al. suggested that overexpression of
TRF2, a telomeric DNA binding protein, increased the rate of
telomere shortening in primary cells without accelerating se-
nescence [5].
The enzyme telomerase consists of the reverse transcriptase
subunit (TERT), which contains the catalytic activity of the
enzyme, and the associated RNA component, which serves as
the template for synthesis of the telomeric sequence [6^9].
Recent publications have underscored the importance of the
catalytic subunit TERT, since introduction of TERT into hu-
man cells extended both their life-span and their telomeres to
lengths typical of young cells [10^12].
The regulation of TERT involves transcriptional and post-
transcriptional mechanisms [13]. Post-transcriptional activa-
tion of the enzymatic activity of TERT by phosphorylation
through the kinases PKC, ERK1/2 and Akt has been shown
[13^16]. Especially for endothelial cells, we demonstrated that
Akt is essential for TERT activation [17]. Moreover, Li et al.
have shown that in the presence of protein phosphatase 2A
(PP2A), but not of protein phosphatase 1 or protein phospha-
tase 2B, telomerase activity is markedly inhibited in vitro,
suggesting that dephosphorylation locks telomerase into an
inactive conformation [18]. Binding of TERT to proteins
seems also to be required for TERT assembly and activity
[19]. The heat shock proteins HSP90, HSP70 and p23 have
been shown to be functionally associated with TERT [19,20].
HSP90 is an abundant and highly conserved protein involved
in di¡erent cellular processes. In contrast to other heat shock
proteins, most of the identi¢ed targets of HSP90 are signaling
proteins [21]. HSP90 acts as a chaperone for unstable signal
transducers and keeps them preserved for activation and for
conformational changes [21]. Geldanamycin and novobiocin
are two competitive inhibitors of HSP90 by binding to the
N-terminus and to the C-terminus of HSP90, respectively,
and thereby interfering with the association of HSP90 with
di¡erent proteins. In particular, novobiocin has been shown
to interfere with Hsc70, p23 and Raf1 binding to HSP90 [22].
In a recent study, Sato et al. identi¢ed the binding site for Akt
to HSP90 at residues 327^340. By binding of Akt to HSP90,
HSP90 protected Akt from PP2A-mediated dephosphoryla-
tion and maintained Akt in its phosphorylated and, thereby,
activated form [23].
Therefore, we investigated whether human TERT (hTERT)
associates with HSP90 and Akt and whether this association
is important for telomerase activity and function. Here, we
report that hTERT associates with HSP90 and Akt in human
embryonic kidney cells as well as in endothelial cells. This
association in concert with phosphorylation of hTERT is re-
quired for telomerase activity. PP2A reduced telomerase ac-
tivity, suggesting a PP2A-sensitive phosphorylation of hTERT.
Moreover, protein complex formation and phosphorylation of
hTERT is also necessary to inhibit apoptosis and caspase-3
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activity, suggesting that the regulation of telomerase activity
and its anti-apoptotic e¡ect is post-transcriptionally modu-
lated by phosphorylation and the interaction with binding
proteins.
2. Materials and methods
2.1. Cell culture
293 cells were maintained in DMEM containing 10% fetal calf
serum as described [24].
Human umbilical vein endothelial cells (HUVEC) were obtained
from newborn cords and purchased from Clonetics (Cologne, Ger-
many) at passage 0. HUVEC were cultured in endothelial basal me-
dium supplemented with hydrocortisone (1 Wg/ml), bovine brain ex-
tract (12 Wg/ml), gentamicin (50 Wg/ml), amphotericin B (50 ng/ml),
epidermal growth factor (10 ng/ml), and 10% fetal calf serum. After
detachment with trypsin, cells were grown for at least 18 h.
2.2. Transfection
The plasmid encoding hTERT wt was a gift from Dr. Weinberg [25]
and was subcloned into pcDNA3.1 myc-his (Invitrogen). The phos-
pho-mimetic, active Akt(T308D/S473D) and the non-phosphorylat-
able Akt(T308A/S473A) were cloned as previously described [26].
PP2A wt was cloned out of a cDNA library (fetal liver human) and
subcloned into pcDNA4 his (Invitrogen). The leucine at position 199
was mutated to proline using site-directed mutagenesis, generating the
dominant negative PP2A(L199P) construct. HUVEC were transfected
with 3 Wg plasmid and 25 Wl Superfect as described previously with a
transfection e⁄ciency of 40% obtained by counting L-galactosidase-
positive cells after transfection of lacZ in pcDNA3.1 myc-his (Invi-
trogen) [27].
293 cells were transfected with Lipofectamine/Plus according to the
manufacturer’s protocol (Gibco BRL) as previously described with a
transfection e⁄ciency of 95% obtained by counting L-galactosidase-
positive cells after transfection of lacZ in pcDNA3.1 myc-his (Invi-
trogen) [24]. The ¢nal amount of transfected DNA for a 60 mm dish
was 1.3 Wg DNA.
2.3. Telomerase activity measurement
Telomerase activity was measured using a commercially available
polymerase chain reaction (PCR)-based assay according to the man-
ufacturer’s protocol (Roche) as described previously [28]. TRAP as-
says were performed using biotin-labeled TS primers (provided with
the assay). After PCR ampli¢cation, PCR products were resolved on a
12% non-denaturing polyacrylamide gel. After transfer to positively
charged nylon membranes, the 6 bp telomerase-speci¢c ladder was
detected using streptavidin^horseradish peroxidase and the enhanced
chemiluminescence system (Amersham). The linearity of the assay was
assured by the positive controls provided by the company; as a neg-
ative control H2O was used containing the biotinylated primers.
2.4. Immunoprecipitation and immunoblotting
Cells were lysed in RIPA bu¡er (50 mM Tris^HCl pH 8.0, 150 mM
NaCl, 1% Nonidet P40, 0.5% deoxycholic acid, 0.1% sodium dodecyl
sulfate (SDS)). 300^500 Wg protein of cell lysate was immunoprecipi-
tated with 5 Wg HSP90 antibody (mouse, Transduction Laboratories),
5 Wg myc antibody (sc-40, mouse, Santa Cruz) or 5 Wg Akt antibody
(clone 5G3, mouse, Cell Signaling) overnight at 4‡C. After incubation
with A/G Plus agarose for 2 h at 4‡C, resulting beads were washed
with lysis bu¡er four times. Agarose beads were subjected to SDS^
polyacrylamide gel electrophoresis (PAGE) sample bu¡er and dis-
solved on a 10% SDS^PAGE.
Immunoblotting was performed with antibodies directed against
HSP90 (overnight, 4‡C, 1:500, Transduction Laboratories), phos-
pho-Ser473-Akt (overnight, 4‡C, 1:500, Cell Signaling), myc (2 h,
room temperature, 1:250, Santa Cruz), tubulin (2 h, room temper-
ature, 1:500, Neomarkers), and Akt (overnight, 4‡C, 1:500, Cell Sig-
naling). Antibodies were detected by the enhanced chemiluminescence
system (Amersham).
2.5. Detection of apoptosis
Cells were washed with phosphate-bu¡ered saline (PBS) and ¢xed
in 4% formaldehyde. Cells were stained with 4P,6-diamidinophenylin-
dole (DAPI; 0.2 Wg/ml in 10 mM Tris^HCl, pH 7, 10 mM EDTA, 100
mM NaCl) for 30 min. Then, cells were washed with PBS and nuclear
morphology was assessed by £uorescence microscopy. Alternatively,
HUVEC were cotransfected with 2.25 Wg plasmid and 0.75 Wg lacZ
and apoptosis was detected by counting the morphological changes of
the transfected L-galactosidase-positive cells.
Alternatively, detection of cell death was performed by FACS anal-
ysis using annexin V-PE binding and 7-amino-actinomycin (7AAD)
staining (Pharmingen). Annexin V is a Ca2þ-dependent phospholipid
binding protein that has a high a⁄nity to phosphatidylserine, which is
exposed on the cell surface of apoptotic cells. In contrast, 7AAD is
only cell-permeable when the cell membranes are damaged, indicative
of necrotic cell death. Therefore, apoptotic cells were de¢ned as an-
nexin V-positive, 7AAD-negative cells. In brief, cells were trypsinized
from the dish and pelleted. After washing twice with annexin binding
bu¡er (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2, pH 7.4), cell
pellets were resuspended in 50 Wl of annexin binding bu¡er and incu-
bated with 2.5 ng/ml annexin V-PE and 2.5 ng/ml 7AAD for 20 min.
The reaction was terminated by adding 250 Wl of annexin binding
bu¡er and analyzed using FACS.
2.6. Caspase activity
For detection of caspase-3 activity, HUVEC were lysed in bu¡er
(1% Triton X-100, 0.32 M sucrose, 5 mM EDTA, 1 mM phenylmeth-
ylsulfonyl £uoride, 1 Wg/ml aprotinin, 1 Wg/ml leupeptin, 2 mM di-
thiothreitol, 10 mM Tris^HCl, pH 8) for 15 min, 4‡C, followed by
centrifugation (20 000Ug, 10 min). Caspase-3 activity was detected in
resulting supernatants using the £uorogenic substrate 7-amino-4-cou-
marin-DEVD as described previously [27].
2.7. Statistics
Statistical analysis was performed with Student’s t-test or ANOVA
(SPSS Software).
3. Results
3.1. HSP90 and Akt associate with TERT
First, we wanted to address whether HSP90, Akt and TERT
were associated with each other. Since we were not able to
immunoprecipitate endogenous hTERT with commercially
available antibodies, we transfected endothelial cells with
myc-tagged hTERT wt and performed an immunoprecipita-
tion directed against HSP90, Akt or the myc tag. We found
that Akt and hTERT were in complex with HSP90 (Fig. 1A
and data not shown). Similar results were also obtained in 293
cells, suggesting that the complex formation is not cell-speci¢c
(data not shown).
3.2. Association of HSP90 and Akt with hTERT is required for
telomerase activity
To investigate the functional role of the association between
HSP90, Akt and hTERT for the activity of telomerase, we
used novobiocin, a coumarin-type antibiotic. Novobiocin is
a competitive inhibitor for association of HSP90 to di¡erent
proteins by binding to the C-terminus [22]. Recently, we
showed that the phosphoinositide 3-kinase (PI3-kinase)/Akt
pathway is required for telomerase activity in endothelial cells
using the pharmacological inhibitor of PI3-kinase, Ly294002
[17]. Sato et al. showed that phosphorylation of Akt is depen-
dent on maintaining HSP90 binding to Akt. Therefore, it is
tempting to speculate that novobiocin may in£uence the asso-
ciation of hTERT with Akt and HSP90. Indeed, novobiocin
reduced the association of Akt and HSP90 and hTERT (Fig.
1A,B). Next, we investigated the e¡ect of novobiocin on Akt
phosphorylation and activation. As shown in Fig. 1C, treat-
ment of endothelial cells with novobiocin reduced phosphor-
ylation of Akt in a concentration-dependent manner. To de-
termine whether the association of Akt, HSP90 and hTERT
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plays a role in maintaining telomerase activity, we incubated
cells with novobiocin. Incubation with novobiocin reduced
telomerase activity in a concentration-dependent manner
with an IC50 of 233 WM (Fig. 1D). Taking into account that
inhibition of the PI3-kinase pathway by Ly294002 reduced
telomerase activity [17], we compared the e¡ects of
Ly294002 and novobiocin. As demonstrated in Fig. 1E,
Ly294002 and novobiocin had comparable inhibitory e¡ects
on telomerase activity. In contrast, geldanamycin, another
competitive inhibitor, which binds to the N-terminus of
Fig. 1. A: Novobiocin disrupts the association of HSP90, hTERT wt and Akt. Endothelial cells were incubated with or without 300 WM novo-
biocin for 18 h and HSP90 was immunoprecipitated. The membranes were cut and the upper part was immunoblotted with anti-myc antibody
(upper panel) and the lower part was immunoblotted with anti-Akt antibody (lower panel). Membranes were stripped and reprobed with an
anti-HSP90 antibody (middle panel). Anti-mouse immunoglobulin was used to check the immunoprecipitation. B: Blots were quanti¢ed by
scanning densitometry using the Scion Image program (n=6). Data are meansUS.E.M. C: Novobiocin inhibits phosphorylation of Akt in a
concentration-dependent manner. Endothelial cells were incubated with di¡erent novobiocin concentrations as indicated for 18 h. Immunoblot-
ting was performed using an anti-S473 phospho-Akt antibody (upper panel). Membranes were stripped and reprobed with an anti-Akt antibody
(middle panel). Blots were quanti¢ed by scanning densitometry using the Scion Image program (n=4). Data are meansUS.E.M. (lower panel).
D: Novobiocin inhibits telomerase activity. Endothelial cells were incubated for 18 h with di¡erent concentrations of novobiocin as indicated.
After cell lysis, telomerase activity was measured in the resulting cell lysates (n=6). Data are meansUS.E.M. E: Ly294002 and novobiocin in-
hibit telomerase activity to a similar extent. Endothelial cells were incubated with 10 WM Ly294002, 600 WM novobiocin or 10 WM geldanamy-
cin for 18 h and telomerase activity was measured (n=6). Data are meansUS.E.M. F: Ly294002 and novobiocin inhibit telomerase activity to
a similar extent. 293 cells were incubated with 10 WM Ly294002, 600 WM novobiocin or 10 WM geldanamycin for 18 h and telomerase activity
was measured (n=6). Data are meansUS.E.M.
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HSP90 and thereby interferes with the association of HSP90
with di¡erent proteins [21], had no e¡ect on telomerase activ-
ity in endothelial cells (Fig. 1E). Similar results for telomerase
activity were obtained when 293 cells were treated with
Ly294002, novobiocin or geldanamycin (Fig. 1F).
3.3. E¡ect of Akt and PP2A on telomerase activity
Having demonstrated that novobiocin reduced telomerase
activity by inhibiting complex formation of hTERT with Akt
and HSP90 and phosphorylation of Akt, we asked whether
novobiocin-induced dephosphorylation and inactivation of
Akt accounts for the inhibitory e¡ect of novobiocin on telo-
merase activity. Therefore, we overexpressed a phospho-mi-
metic, active Akt construct, Akt(T308D/S473D), and a non-
phosphorylatable Akt construct, Akt(T308A/S473A). It has
previously been demonstrated that Akt(T308D/S473D) inhib-
ited apoptosis in di¡erent cell types and that Akt(T308A/
S473A) reduced telomerase activity [17,29]. As shown in
Fig. 2A, overexpression of the active Akt(T308D/S473D) con-
struct inhibited the novobiocin-induced reduction of telo-
merase activity. In contrast, the non-phosphorylatable Akt-
(T308A/S473A) further reduced novobiocin-induced reduction
of telomerase activity in endothelial cells (Fig. 2A). These data
indicate that phosphorylation of hTERT by Akt may be re-
quired for telomerase activity. Our data demonstrated that
association of TERT/HSP90/Akt and phosphorylation of
hTERT by Akt are important to maintain telomerase activity.
However, it is not clear whether HSP90 has a direct e¡ect on
TERT or whether HSP90 keeps Akt in its active state and
thereby maintains TERT phosphorylated. Because binding of
HSP90 to Akt protected Akt from PP2A-mediated dephos-
phorylation in vitro [23], we cloned PP2A wt and the domi-
nant negative PP2A(L199P) construct [30]. PP2A(L199P) has
been shown to be catalytically impaired when transfected into
yeast [30]. We found that under basal conditions overexpres-
sion of PP2A wt into 293 cells results in a signi¢cant reduction
of telomerase activity compared to vector-transfected cells
(vector-transfected cells : 0.875U 0.034 OD/mg protein, PP2A
wt-transfected cells : 0.698U 0.041 OD/mg protein). In con-
trast the dominant negative construct PP2A(L199P) enhanced
telomerase activity (Fig. 2B). To further delineate the e¡ect of
PP2A on the inhibitory e¡ect of novobiocin on telomerase
activity, we incubated cells overexpressing PP2A(L199P)
with novobiocin. As shown in Fig. 2B, overexpression of
PP2A(L199P) blocked the novobiocin e¡ect, demonstrating
that dephosphorylation by PP2A is important for maintaining
telomerase activity. Of note, PP2A consists of several subunits
and it has been suggested that reconstituting the holoenzyme
in vivo could be di⁄cult [30]. Therefore, we additionally
treated 293 cells with okadaic acid to inhibit PP2A activation.
As shown in Fig. 2B, okadaic acid completely inhibited no-
vobiocin-induced reduction of telomerase activity.
3.4. Novobiocin induced apoptosis and caspase activity in
endothelial cells
Besides the well known function of TERT in counteracting
telomere shortening, TERT has been suggested to exert anti-
apoptotic functions [31,32]. To address the question whether
complex formation of hTERT, HSP90 and Akt and phos-
phorylation are also necessary for the anti-apoptotic function
of hTERT, we investigated whether novobiocin can induce
apoptosis in endothelial cells and human embryonic kidney
cells. Incubation with novobiocin for 18 h resulted in a con-
centration-dependent increase in the number of apoptotic cells
as measured by FACS analysis and nuclear staining with
DAPI (Fig. 3A and data not shown). The apoptosis induction
by novobiocin was associated with an induction of caspase-3-
like activity (Fig. 3B). Taking into account that overexpres-
sion of the active, phospho-mimetic Akt(T308D/S473D) con-
struct restored telomerase activity after novobiocin treatment,
we further investigated the e¡ect of this construct on novo-
biocin-induced apoptosis. As demonstrated in Fig. 3C, over-
expression of Akt(T308D/S473D) inhibited novobiocin-
induced apoptosis, suggesting that the association between
HSP90, Akt and hTERT in concert with the phosphorylation
of TERT by Akt is necessary not only for maintaining telo-
merase activity, but also for inhibiting apoptosis. As expected,
Fig. 2. A: E¡ects of Akt(T308D/S473D) and Akt(T308A/S473A) on
novobiocin-induced reduction of telomerase activity in HUVEC.
HUVEC were transfected with vector, Akt(T308D/S473D) or Akt
(T308A/S473A) and incubated with 300 WM novobiocin for 18 h.
After cell lysis, telomerase activity was measured in the resulting
cell lysates (n=6). Data are meansUS.E.M. *P6 0.05 versus vector-
transfected cells ; **P6 0.05 versus vector-transfected cells+novobio-
cin. B: E¡ect of PP2A(L199P) and okadaic acid on novobiocin-in-
duced reduction of TERT activity. 293 cells were transfected with
vector or PP2A(L199P). Cells were incubated with 300 WM novobio-
cin for 18 h in the presence or absence of 10 nM okadaic acid as
indicated. After cell lysis, telomerase activity was measured in
the resulting cell lysates (n=4). Data are meansUS.E.M. *P6 0.05
versus vector-transfected cells+novobiocin. The inset demonstrates
overexpression of PP2A(L199P)-Xpress.
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overexpression of the non-phosphorylatable construct Akt-
(T308A/S473A) did not exert any inhibitory e¡ect on apopto-
sis induction (Fig. 3C).
4. Discussion
The activity of the active subunit of the telomerase TERT is
regulated by various post-transcriptional mechanisms includ-
ing binding to heat shock proteins [13,19,20]. The present
study demonstrates that TERT is associated not only with
HSP90 but also with the protein kinase Akt. The binding of
HSP90 to TERT was shown to be essential for the assembly
of the telomerase complex [19]. Moreover, inhibition of
HSP90 function in cells blocks assembly of active telomerase
[19]. The underlying mechanism, however, is not fully eluci-
dated. HSP90 is known to play a crucial role in regulation of
various intracellular signaling pathways. Importantly, HSP90
prevents Akt inactivation by inhibiting dephosphorylation at
Ser473 in vitro [23]. The preservation of Akt activity is medi-
ated by interaction of Akt with HSP90 at residues 327^340,
which is in close vicinity to the novobiocin binding site within
HSP90. The present study now demonstrates that novobiocin
leads to a dephosphorylation of Akt and inhibits Akt/HSP90
complex formation. In addition, novobiocin interfered with
Fig. 3. A: Novobiocin induces apoptosis in endothelial cells. Endothelial cells were incubated with di¡erent novobiocin concentrations as indi-
cated for 18 h. Apoptosis was measured by FACS analysis with annexin V-PE staining (n=5). A representative FACS analysis is shown.
B: Novobiocin induces caspase-3-like activity in endothelial cells. Endothelial cells were incubated with di¡erent novobiocin concentrations as
indicated for 18 h. Cells were lysed and caspase-3-like activity was measured as described in Section 2 (n=3). Data are meansUS.E.M.
*P6 0.05 versus cells treated with 75 WM novobiocin. C: Endothelial cells were cotransfected with vector and lacZ, Akt(T308D/S473D) and
lacZ or Akt(T308A/S473A) and lacZ in a ratio of 3:1. After incubation with 300 WM novobiocin for 18 h, cells were stained with L-galactosi-
dase and apoptosis was detected by counting the morphological changes of the transfected cells (n=4). Data are meansUS.E.M. *P6 0.01 ver-
sus vector-transfected cells+novobiocin.
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the HSP90^TERT complex and potently inhibited telomerase
activity. Interestingly, prevention of Akt dephosphoryla-
tion by overexpression of a phospho-mimetic Akt construct
blocked novobiocin-induced inactivation of telomerase. These
data would suggest that inactivation of telomerase induced by
novobiocin is mainly caused by disruption of Akt^HSP90
interaction and consequent dephosphorylation and inactiva-
tion of Akt. Previous studies have shown that Akt can phos-
phorylate TERT and enhance its enzymatic activity in vitro
[15,17].
Moreover, the data of the present study suggest that com-
plex formation of hTERT with HSP90 and Akt in concert
with hTERT phosphorylation is important for telomerase ac-
tivity. Since telomerase activity is required to maintain telo-
mere length at the end of the chromosomes in the nucleus, it is
tempting to speculate that the HSP90^Akt^TERT complex
may be formed in the nucleus. Preliminary data of our labo-
ratory suggested that HSP90, Akt and TERT protein can be
detected in nuclear fractions of cell lysates, underscoring the
possibility of complex formation between HSP90, Akt and
TERT in the nucleus (data not shown). The question remains
how the complex is formed. It is tempting to speculate that
after assembly of the TERT holoenzyme, which requires p23
and HSP90 [19], Akt may be recruited into the complex to
phosphorylate and thereby fully activate TERT. However,
further studies are required to address this question.
The dephosphorylation of Akt after disruption of the
HSP90^Akt complex is mediated by PP2A in vitro [23].
Therefore, we investigated the contribution of PP2A for no-
vobiocin-mediated TERT inactivation. Inhibition of PP2A by
overexpression of a dominant negative construct prevent-
ed novobiocin-induced inactivation of TERT. In addition,
PP2A wt reduced basal telomerase activity. These data are
consistent with the concept that novobiocin exerts its inhibi-
tory e¡ects by allowing PP2A-mediated Akt inactivation.
However, PP2A also markedly inhibited telomerase activity
in vitro and this inhibition, also observed in human melanoma
cell lysates, is mimicked by non-speci¢c protein phosphatase
alkaline phosphatase and prevented by the PP2A inhibitor
okadaic acid [15,18]. Therefore, we cannot rule out that
PP2A also exerts a direct e¡ect on telomerase activity beside
the inhibition of Akt-dependent phosphorylation. However,
direct TERT inactivation by PP2A was only demonstrated
in vitro [15,18], therefore further studies are necessary to ad-
dress that point under in vivo conditions. At least, PP2A wt
did not associate with hTERT wt (data not shown) and did
not a¡ect the enzymatic activity of TERT, when the phospho-
mimetic Akt construct was co-transfected (data not shown).
In contrast to the study of Holt et al. [19], the inactivation
of TERT was only detectable with novobiocin but not with
geldanamycin, which speci¢cally blocks N-terminal interac-
tion of HSP90. One reason for this discrepancy could be the
di¡erent experimental set-ups and possible cell type speci¢c-
ities. Whereas in our study endothelial cells and 293 cells were
maintained under serum-containing conditions, the HT1080
cells used by Holt et al. were serum-starved for 14 days [19].
One might argue that in endothelial cells and 293 cells, HSP90
interacts via novobiocin-sensitive C-terminal interaction with
Akt thereby promoting Akt-dependent phosphorylation of
TERT. In contrast, direct interaction of TERT with HSP90
as described by Holt et al., which is sensitive to both gelda-
namycin and novobiocin, might not take place under our ex-
perimental conditions. This is in accordance with the ¢nding
that geldanamycin did not disturb TERT complex formation
with HSP90 or Akt in our hands (data not shown).
Besides the well known function of TERT to elongate telo-
meres, TERT has also been shown to exert an anti-apoptotic
function [31,32]. Thus, inhibition of TERT activity by over-
expression of a dominant negative mutant or antisense oligo-
nucleotides induced apoptosis [31^33]. Likewise, in our study
inhibition of telomerase activity by novobiocin was associated
with increased apoptosis of endothelial cells. Importantly, no-
vobiocin-induced apoptosis was only prevented by overexpres-
sion of a phospho-mimetic Akt construct. These data are in
accordance with the measurement of telomerase activity and
support the conclusion that TERT phosphorylation renders
the enzyme resistant against the inhibitory e¡ect of novobio-
cin.
Taken together, our data suggest that telomerase activity
and its anti-apoptotic function are regulated by association
of TERT with Akt and HSP90 and consequently phosphory-
lation of TERT. The present study con¢rms previous reports
that HSP90 is essential to maintain Akt in its phosphorylated
and, thus, active state by preventing dephosphorylation by
PP2A [23]. Thus, maintaining the association of HSP90, Akt
and TERT may importantly contribute to the life-span of
endothelial cells and to the integrity of the endothelial cell
monolayer by protecting against apoptosis.
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